![Wolfgang Hanisch](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Wolfgang Hanisch
Vorstandsvorsitzender bei Hospira Adelaide Pty Ltd.
Aktive Positionen von Wolfgang Hanisch
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Hospira Adelaide Pty Ltd.
![]() Hospira Adelaide Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Hospira Adelaide Pty Ltd. engages in the provision of biotechnology and research services. It also develops cell therapy technology. It offers biopharmaceutical API products including hGH, a treatment for human growth hormone deficiency; G-CSF, which is used in the treatment of leukemia; and Interferon alpha for chronic hepatitis B and C. The company was founded in 1982 and is headquartered in Thebarton, Australia. | Vorstandsvorsitzender | - | - |
Karriereverlauf von Wolfgang Hanisch
Ehemalige bekannte Positionen von Wolfgang Hanisch
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TBG DIAGNOSTICS LIMITED | Direktor/Vorstandsmitglied | 01.07.2009 | 01.07.2009 |
Independent Dir/Board Member | 27.03.2009 | 01.07.2009 | |
VIRALYTICS LTD. | Direktor/Vorstandsmitglied | - | 10.04.2006 |
Statistik
International
Australien | 4 |
Operativ
Director/Board Member | 2 |
Chief Executive Officer | 1 |
Independent Dir/Board Member | 1 |
Sektoral
Health Technology | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Viralytics Pty Ltd.
![]() Viralytics Pty Ltd. BiotechnologyHealth Technology Viralytics Pty Ltd. engages in the development and commercialization of oncolytic immunotherapies that harness the power of certain viruses to infect and kill cancer cells. Its product, CAVATAK, is a genetically unmodified proprietary formulation of the common cold Coxsackievirus Type A21. The company was founded in 1984 and is headquartered in Sydney, Australia. | Health Technology |
Hospira Adelaide Pty Ltd.
![]() Hospira Adelaide Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Hospira Adelaide Pty Ltd. engages in the provision of biotechnology and research services. It also develops cell therapy technology. It offers biopharmaceutical API products including hGH, a treatment for human growth hormone deficiency; G-CSF, which is used in the treatment of leukemia; and Interferon alpha for chronic hepatitis B and C. The company was founded in 1982 and is headquartered in Thebarton, Australia. | Commercial Services |
TBG Diagnostics Ltd.
![]() TBG Diagnostics Ltd. Pharmaceuticals: MajorHealth Technology TBG Diagnostics Ltd. engages in the research, development, and manufacture of biopharmaceuticals. It operates through the InVitro Diagnostics segment, which involves in the research of biological drugs and the retail and wholesale of veterinary drugs. The company was founded on September 26, 1989 and is headquartered in Melbourne, Australia. | Health Technology |
- Börse
- Insiders
- Wolfgang Hanisch
- Erfahrung